Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, UK.
European Cancer Organisation, Brussels, Belgium.
Mol Oncol. 2021 Jul;15(7):1750-1758. doi: 10.1002/1878-0261.13022. Epub 2021 Jun 15.
We have reached a watershed moment in Europe in our efforts to ensure increased survival and better outcomes for cancer patients. The EU Cancer Mission and the European Beating Cancer Plan together provide an unrivalled opportunity to make significant inroads into a disease that kills over 1.7 million European citizens annually. Harnessing these twin pillars of cancer research and cancer control can be transformative for the European cancer community and in particular for the European cancer patient. However, from a research perspective, in order to fully realise these benefits, we need to ensure that all aspects of the cancer continuum are addressed. Previous research efforts have focussed more on the diagnosis and treatment of cancer, whereas cancer survivorship, to date, has been overlooked. Here, we aim to redress this balance, by identifying the key challenges in cancer survivorship research that need to be addressed and proposing a series of recommended solutions, which, if acted upon, would deliver significant benefits for the nearly 20 million cancer survivors in Europe. To achieve this, we propose the development of a clearly articulated and sustainably funded European Cancer Survivorship Research and Innovation Plan. Embedding this plan within the framework of the EU Cancer Mission would be transformative for cancer survivors and society.
在努力确保癌症患者生存率提高和改善预后方面，欧洲正迎来一个关键时刻。欧盟癌症行动计划和欧洲抗癌计划为深入研究这一每年导致 170 多万欧洲公民死亡的疾病提供了绝佳机会。癌症研究和癌症控制这两个支柱若能协同发挥作用，将为欧洲癌症界带来变革，尤其将使欧洲癌症患者受益。然而，从研究角度来看，为了充分实现这些益处，我们需要确保解决癌症连续体的各个方面。以前的研究工作更多地集中在癌症的诊断和治疗上，而癌症生存问题迄今一直被忽视。在此，我们旨在纠正这种不平衡，确定癌症生存研究中需要解决的关键挑战，并提出一系列建议解决方案，如果付诸实施，将为欧洲近 2000 万癌症幸存者带来重大惠益。为实现这一目标，我们建议制定一个明确阐述和可持续供资的欧洲癌症生存研究和创新计划。将该计划纳入欧盟癌症行动计划的框架内，将为癌症幸存者和社会带来变革。
